These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4991597)

  • 21. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on the sensitivity of a passive hemagglutination test in the detection of antimeasles antibodies.
    Ghyka GR; Cernescu C; Cajal N
    Rev Roum Virol (1972); 1973; 10(4):295-300. PubMed ID: 4207146
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison between haemagglutination inhibition test and enzyme immunoassay for evaluation of measles immune status and seroconversion to measles vaccine.
    Gebreselassie L; Melamed MD
    Ethiop Med J; 1983 Jul; 21(3):139-42. PubMed ID: 6349985
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimum age for measles immunisation: study of pre- and post-immunization level of HI antibody titres.
    Bhatnagar SK; Mohan M; Kumar P; Balaya S; Prabhakar AK; Bhargava SK
    Indian Pediatr; 1981 Sep; 18(9):625-9. PubMed ID: 6797943
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody.
    Polack FP; Auwaerter PG; Lee SH; Nousari HC; Valsamakis A; Leiferman KM; Diwan A; Adams RJ; Griffin DE
    Nat Med; 1999 Jun; 5(6):629-34. PubMed ID: 10371500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass immunization of children in Iran with live attenuated Sugiyama measles virus adapted to calf kidney cell cultures.
    Mirchamsy H; Shafyi A; Bahrami S; Nazari P; Mirzadeh M; Bassali Y
    Jpn J Exp Med; 1971 Feb; 41(1):39-48. PubMed ID: 5313449
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical trials with a rabies vaccine of tissue culture origin.
    Loofbourow JC; Cabasso VJ; Roby RE; Cooper TY
    J Am Coll Health Assoc; 1972 Feb; 20(3):228-30. PubMed ID: 5061702
    [No Abstract]   [Full Text] [Related]  

  • 29. [Potency test of measles vaccines from inactivated viruses. II. Calculation by a new estimating formula].
    von Mettenheim AE
    Zentralbl Bakteriol Orig; 1968; 207(2):158-65. PubMed ID: 5744277
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of two further attenuated live measles-virus vaccines.
    Krugman S; Constantinidis P; Medovy H; Giles JP
    Am J Dis Child; 1969 Feb; 117(2):137-8. PubMed ID: 5763824
    [No Abstract]   [Full Text] [Related]  

  • 33. Production of reaginic antibody, in monkeys, following immunization with dialyzable constituants of timothy pollen extracts.
    Girard JP; Hampai A
    Int Arch Allergy Appl Immunol; 1970; 37(6):561-74. PubMed ID: 4983345
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative evaluation of 3 measles vaccines. 3. Evaluation of the hemagglutination inhibition test for assaying measles antibodies after vaccination].
    Polna I; Naruszewicz-Lesiuk D; Pilecka T
    Przegl Epidemiol; 1970; 24(3):339-47. PubMed ID: 5482214
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of measles neutralizing and hemagglutination-inhibition antibody titers in individual sera.
    Fulginiti VA; Kempe CH
    Am J Epidemiol; 1965 Sep; 82(2):135-42. PubMed ID: 5828888
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical reactions following vaccination with two types of live virus measles vaccines.
    Garber HJ; Witte JJ; Tayback M; Latta R; Kelley E
    JAMA; 1968 Jul; 205(5):309-11. PubMed ID: 5694946
    [No Abstract]   [Full Text] [Related]  

  • 37. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

  • 38. Antigenic and immunogenic properties of components contained in rabies virus-infected tissue culture fluids.
    Schlumberger HD; Wiktor TJ; Koprowski H
    J Immunol; 1970 Aug; 105(2):291-8. PubMed ID: 5433693
    [No Abstract]   [Full Text] [Related]  

  • 39. Increasing attenuation of measles virus strain Sugiyama during serial passage in calf kidney cells.
    Kawana R; Kaneko M; Wako H; Iwai T; Kawana M
    Jpn J Exp Med; 1970 Aug; 40(4):257-63. PubMed ID: 5312395
    [No Abstract]   [Full Text] [Related]  

  • 40. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.